Meet the team

Martina Molsbergen
C14 Consulting Group, LLC

Martina Molsbergen has more than 23 years of business development, marketing and entrepreneurial experience – including more than a decade of business development experience in biotherapeutics and antibodies. She has proven corporate development strategy and leadership experience within large and small company settings. Before her role as CEO of C14 Consulting, a premier provider of business strategy and licensing and deal negotiation, Ms. Molsbergen was the Vice President of Business Development (PER.C6 Licensing) at Crucell Holland BV. In this capacity she established the PER.C6 manufacturing technology platform for therapeutic antibodies and proteins, managed the global business development team and the company’s joint venture with DSM Biologics. To date, she has brought more than twenty new licensing opportunities.

Earlier, Ms. Molsbergen served as Vice President of Business Development for BioWa, Inc., for which she played a key role in establishing and building the novel antibody engineering platform company as a subsidiary of the Japanese company, Kyowa Hakko Kogyo (KHK). In three years of business activity, she successfully negotiated more than 15 deals valued at over $2.5 billion in future milestone payment and royalties with leading antibody and biopharma companies. She participated with KHK to identify new investment opportunities, and strategic planning for internal product pipeline development. The efforts led to the creation of market value of BioWa to reach over $1 billion in three years. Ms. Molsbergen received two President’s awards for her achievements. She has been featured in Nikkei Magazine for her business deal achievements with and on behalf of Japanese companies (May 2007 and June 2012).

In addition, Ms Molsbergen has more than ten years of business development experience in small molecule pharmaceutical and manufacturing companies, including Patheon, Watson Pharmaceuticals and FMC Corporation. She holds a BS in Chemical Engineering from Drexel University.

Email Martina Molsbergen at